<DOC>
	<DOCNO>NCT02253108</DOCNO>
	<brief_summary>The purpose study compare early vessel heal implantation SYNERGY drug elute stent ( DES ) BioMatrix NeoFlex DES one three month two cohort .</brief_summary>
	<brief_title>The OCT SORT-OUT VIII Study</brief_title>
	<detailed_description>Prospective , open label , single blind , randomize study inclusion 160 patient two equal size cohort ( A B ) . Angiographic follow-up optical coherence tomography ( OCT ) perform 1 month ( Cohort A ) 3 month ( Cohort B ) . Randomization 1:1 SYNERGY BioMatrix Neoflex . The Cohorts include consecutively , Cohort A first .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients &gt; 18 year treat one drugeluting stent coronary artery Aarhus University Hospital Odense University Hospital Age &lt; 18 year Do wish participate Unable provide write informed consent Domicile outside Denmark Do speak Danish Inclusion SORTOUT VIII study Inclusion stent study Expected survival &lt; 1 year Allergy aspirin , clopidogrel , prasugrel ticagrelor Hypersensitivity everolimus biolimus The operator wish use DES Reduced renal function ; creatinine &gt; 120 mmol / L Only bare metal stent ( BMS ) implantation Only plain old balloon angioplasty ( POBA )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>DES</keyword>
	<keyword>Angina pectoris</keyword>
	<keyword>Stent</keyword>
	<keyword>Optical coherence tomography</keyword>
	<keyword>Stent thrombosis</keyword>
</DOC>